Chargement en cours...
Tobramycin inhalation powder for P. aeruginosa infection in cystic fibrosis: the EVOLVE trial
Tobramycin inhalation solution is used to treat chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients. We evaluated the efficacy and safety of a novel, light-porous-particle, dry-powder formulation of tobramycin, which was developed to improve delivery efficiency to the airways a...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4112574/ https://ncbi.nlm.nih.gov/pubmed/20963831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.21356 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|